Select Publications

Journal articles

Khojasteh Zonoozi A; Abolghasemi FS; Ahmadi P; Bisch M; Butner JL; Chow KWD; Conti AA; Danesh A; Ebrahimi M; El-Khoury J; Farhoudian A; Jouzdani AF; Guterstam J; Hernández MDM; Jokūbonis D; Kathiresan P; Krupitsky EM; Lee SY; Long J; Maremmani I; Miovský M; Mooney L; Nielsen S; Rafei P; Rodgers C; Rúnarsdóttir V; Sevarino KA; Somaini L; Vista SBD; Vossenberg P; Wojnar M; Yee A; Zare-Bidoky M; Ambekar A; Baldacchino A; Potenza MN; Ekhtiari H, 2026, 'Global perspectives on treatment and harm reduction services for opioid use disorder: Results from an international survey', International Journal of Drug Policy, 156, http://dx.doi.org/10.1016/j.drugpo.2026.105448

Santo T; Bharat C; Rodgers C; Harrod M; Taylor S; Zahra E; Sutherland R; Peacock A; Grebely J; Hickman M; Farrell M; Degenhardt L, 2026, 'Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence Survey', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70132

Sutherland R; Steele M; Rodgers C; Silins E; Gilliver R; Peacock A; Barratt M; Ezard N; Siefried KJ; Page R; Bruno R; Read P, 2025, 'Characteristics of take-home fentanyl test strip use and support for drug checking services among people who use heroin in Australia: learnings for an increasingly complex drug market', Harm Reduction Journal, 22, pp. 75, http://dx.doi.org/10.1186/s12954-025-01205-z

Rance J; Belackova V; Bell J; Dunlop AJ; Ezard N; Jauncey M; Lintzeris N; Oviedo-Joekes E; Ritter A; Roberts DM; Rodgers C; Siefried KJ; Strang J; van den Brink W; Treloar C, 2025, 'Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in Australia', Drug and Alcohol Review, 44, pp. 1533 - 1542, http://dx.doi.org/10.1111/dar.14092

Ritter A; Bell J; Strang J; Ezard N; Rodgers C; Belackova V; Jauncey M; Siefried KJ; Roberts DM; van den Brink W; Lintzeris N; Dunlop A; Oviedo-Joekes E; Treloar C, 2025, 'Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in Australia', International Journal of Drug Policy, 138, pp. 104749, http://dx.doi.org/10.1016/j.drugpo.2025.104749

Settumba S; Shahbazi J; Byrne M; Degenhardt L; Grebely J; Larance B; Nielsen S; Lintzeris N; Ali R; Rodgers C; Blazey A; Weiss R; Dunlop A; McDonough M; Cook J; Farrell M, 2025, 'Provider costs of treating opioid dependence with extended-release buprenorphine in Australia', Drug and Alcohol Review, 44, pp. 179 - 194, http://dx.doi.org/10.1111/dar.13956

Ezard N; Clifford B; Siefried KJ; Ali R; Dunlop A; McKetin R; Bruno R; Carr A; Ward J; Farrell M; Graham R; Haber P; Lubman D; Donoghoe MW; Olsen N; Baker A; Hall M; Arunogiri S; Lintzeris N; Gill A; Rodgers C; Montebello M; Liaw W; Liu Z, 2025, 'Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial', Addiction, 120, pp. 1345 - 1359, http://dx.doi.org/10.1111/add.16730

Rodgers C; Siefried KJ; Ritter A; Belackova V; Treloar C; Jauncey M; Ezard N; Roberts D; Steele M; van den Brink W; Strang J; Oviedo-Joekes E; Lintzeris N; Dunlop AJ; Bell J, 2024, 'Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost', BMJ Open, 14, pp. e082553, http://dx.doi.org/10.1136/bmjopen-2023-082553

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Acheson LS; Clay S; McKetin R; Lintzeris N; Dunlop A; Brett J; Christmass M; Rodgers C; Shoptaw S; Farrell M; Ezard N; Siefried KJ, 2024, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', International Journal of Drug Policy, 126, pp. 104383, http://dx.doi.org/10.1016/j.drugpo.2024.104383

Acheson LS; Gordon C; Mcketin R; Brett J; Christmass M; Rodgers C; Lintzeris N; Dunlop A; Farrell M; Shoptaw S; Ezard N; Siefried KJ, 2024, 'Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility Study', European Addiction Research, 30, pp. 121 - 125, http://dx.doi.org/10.1159/000536328

Siefried KJ; Freeman G; Roberts DM; Lindsey R; Rodgers C; Ezard N; Brett J, 2023, 'Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review', Psychopharmacology, 240, pp. 127 - 135, http://dx.doi.org/10.1007/s00213-022-06283-6

Freeman G; Siefried KJ; Roberts DM; Rodgers C; Nic Ionmhain U; Ramanathan J; Ezard N; Brett J, 2023, 'Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series', Drug and Alcohol Review, 42, pp. 27 - 32, http://dx.doi.org/10.1111/dar.13556

Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial', Drug and Alcohol Dependence, 241, http://dx.doi.org/10.1016/j.drugalcdep.2022.109692

Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal', Plos One, 17, pp. e0275371, http://dx.doi.org/10.1371/journal.pone.0275371

Farrell M; Shahbazi J; Byrne M; Grebely J; Lintzeris N; Chambers M; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Nicholas T; Weiss R; Rodgers C; Cook J; Degenhardt L, 2022, 'Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103492

Wilson H; Schulz M; Rodgers C; Lintzeris N; Hall J; Harris-Roxas B, 2022, 'What do General Practitioners want from Specialist Alcohol and Other Drugs Services? A Qualitative Study of NSW Metropolitan GPs', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13463

Rodgers C, 2018, 'Brief interventions for alcohol and other drug use', Australian Prescriber, 41, pp. 117 - 121, http://dx.doi.org/10.18773/AUSTPRESCR.2018.031

Ezard N; Webb B; Clifford B; Cecilio ME; Jellie A; Lea T; Rodgers C; Ruth S; Bruno R, 2018, 'Substance Use and Sex Index (SUSI): First stage development of an assessment tool to measure behaviour change in sexualised drug use for substance use treatment studies', International Journal of Drug Policy, 55, pp. 165 - 168, http://dx.doi.org/10.1016/j.drugpo.2018.03.020

Rodgers C, 2018, 'An anxious man with codeine dependence: Opioid maintenance therapy', Medicine Today, 19, pp. 35 - 36

Whitlam G; Dinh M; Rodgers C; Muscatello DJ; McGuire R; Ryan T; Thackway S, 2016, 'Diagnosis-based emergency department alcohol harm surveillance: What can it tell us about acute alcohol harms at the population level?', Drug and Alcohol Review, pp. n/a - n/a, http://dx.doi.org/10.1111/dar.12458

Bourne C; Allen D; Brown K; Davies SC; McNulty A; Smith DE; O'Connor CC; Couldwell D; Jackson E; Bolton M; Rodgers C; Konecny P; Smith DJ; Parker A, 2013, 'Corrigendum to: What proportion of sexually transmissible infections and HIV are diagnosed in New South Wales’ public sexual health services compared with other services?', Sexual Health, 10, pp. 290 - 290, http://dx.doi.org/10.1071/sh12020_co

Bourne C; Allen D; Brown K; Davies SC; McNulty A; Smith DE; O’Connor CC; Couldwell D; Jackson E; Bolton M; Rodgers C; Konecny P; Smith DJ; Parker A, 2013, 'What proportion of sexually transmissible infections and HIV are diagnosed in New South Wales’ public sexual health services compared with other services?', Sexual Health, 10, pp. 119 - 123, http://dx.doi.org/10.1071/sh12020

Topp LJ; Day C; Wand HC; Deacon RM; Van Beek IA; Haber PS; Shanahan MD; Rodgers CJ; Maher L, 2013, 'A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia', Preventive Medicine, Advance online publication, pp. 1 - 7, http://dx.doi.org/10.1016/j.ypmed.2013.04.013

Topp L; Day C; Wand H; Deacon R; Van Beek I; Haber P; Shanahan M; Rodgers C; Maher L, 2011, 'A RANDOMISED CONTROLLED TRIAL OF CONTINGENCY MANAGEMENT TO INCREASE HEPATITIS B VACCINATION UPTAKE AND COMPLETION AMONG PEOPLE WHO INJECT DRUGS IN AUSTRALIA', DRUG AND ALCOHOL REVIEW, 30, pp. 86 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700266&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shearer J; Shanahan MD; Darke S; Rodgers CJ; Van Beek IA; McKetin R; Mattick RP, 2010, 'A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence', Drug and Alcohol Review, 29, pp. 235 - 242, http://dx.doi.org/10.1111/j.1465-3362.2009.00148.x

Day C; White B; Dore G; Van Beek I; Rodgers C; Cunningham P; Wodak A; Maher L, 2010, 'Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status', Drug and Alcohol Dependence, 108, pp. 134 - 137, http://dx.doi.org/10.1016/j.drugalcdep.2009.11.013

Shearer J; Darke S; Rodgers CJ; Slade T; Van Beek IA; Lewis J; Brady D; McKetin R; Mattick RP; Wodak AD, 2009, 'A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence', Addiction, 104, pp. 224 - 233, http://dx.doi.org/10.1111/j.1360-0443.2008.02437.x

Bourne CP; Edwards B; Shaw M; Gowers A; Rodgers CJ; Ferson MJ, 2008, 'Sexually transmissible infection testing guidelines for men who have sex with men', Sexual Health, 5, pp. 189 - 191


Back to profile page